Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Cell Reports. Medicine|January 11, 2025
Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinomaXue Qian Wu, Fan Ying, Katherine Po Sin Chung, et al.
Cancer Letters|February 17, 2020
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinomaHoi Wing Leung, Eunice Yuen Ting Lau, Carmen Oi Ning Leung, et al.
Hepatology (Baltimore, Md.)|July 18, 2017
Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significanceXiao-Feng Li, Cheng Chen, Dai-Min Xiang, et al.
The Journal of Clinical Investigation|December 15, 2025
Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated β-catenin activationCarmen Oi Ning Leung, Shilpa Gurung, Katherine Po Sin Chung, et al.
Cell Reports|February 2, 2022
Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancersJialing Shen, Chunxue Yang, Misty Shuo Zhang, et al.
Gut|March 5, 2017
SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loopChun-Ping Cui, Carmen Chak-Lui Wong, Alan Ka-Lun Kai, et al.
The Journal of Pathology|September 2, 2017
The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinomaBin Zhang, Yajing Zhang, Xiaoping Zou, et al.
Journal of Hepatology|November 19, 2020
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinomaYu-Hua Huang, Chris Zhi-Yi Zhang, Qun-Sheng Huang, et al.
Journal of Hepatology|September 12, 2020
RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinomaLo-Kong Chan, Daniel Wai-Hung Ho, Charles Shing Kam, et al.
Cancer Research|June 29, 2022
Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Carmen Oi Ning Leung, Lei Zhou, et al.
Pageof 9